Management of type 2 diabetes: a challenge for patient and physician

被引:58
作者
van den Arend, IJM
Stolk, RP [1 ]
Krans, HMJ
Grobbee, DE
Schrijvers, AJP
机构
[1] Univ Utrecht, Sch Med, Julius Ctr Patient Oriented Res, Utrecht, Netherlands
[2] Univ Leiden Hosp, Dept Endocrinol & Metab Dis, NL-2300 RC Leiden, Netherlands
关键词
disease management; education; diabetes team;
D O I
10.1016/S0738-3991(99)00067-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Type 2 diabetes mellitus is a chronic disease, associated with serious complications and co-morbidity and considerable costs. The number of people with diabetes mellitus is expected to increase with 40% in the next decade, due to prolonged life expectancy, the ageing of the population and developments in the health care sector, including more active screening strategies. The majority (40-60%) of type 2 diabetes patients in routine GP practice have a poor metabolic control (HbAlc > 8% or fasting blood glucose > 11 mmol/l). In this paper the obstacles in routine clinical practice for optimal type 2 diabetes care are discussed. Long-term complications are the major cause of morbidity and mortality in type 2 diabetes patients. Therefore, the primary aim of type 2 diabetes management is the prevention of complications, by lowering blood glucose levels and reducing the cardiovascular risk profile. An important component of type 2 diabetes management is an active role of the patient: diet, smoking habits, physical exercise and self-care behavior often need to change. In addition, the patient has to adhere to life long medical therapy. Motivating the patient for this active role is the challenge for health care providers. A complicating factor is that changes in lifestyle do not give immediate benefit for the patient, as the effects are seen in the reduction of the development of long-term complications. The cornerstones of health care to support active patient participation are: to guarantee the continuity of care, to integrate education in health care and to encourage the patient's attendance. It is the challenge for physicians to give type 2 diabetes patients the tools for active participation in the management of the disease. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:187 / 194
页数:8
相关论文
共 30 条
[21]  
RUWAARD D, 1994, PUBLIC HLTH STATUS F
[22]  
SCHRIJVERS AJP, 1997, HLTH HLTH CARE NETHE
[23]   THE EFFECT OF INTENSIVE TREATMENT OF DIABETES ON THE DEVELOPMENT AND PROGRESSION OF LONG-TERM COMPLICATIONS IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
SHAMOON, H ;
DUFFY, H ;
FLEISCHER, N ;
ENGEL, S ;
SAENGER, P ;
STRELZYN, M ;
LITWAK, M ;
WYLIEROSETT, J ;
FARKASH, A ;
GEIGER, D ;
ENGEL, H ;
FLEISCHMAN, J ;
POMPI, D ;
GINSBERG, N ;
GLOVER, M ;
BRISMAN, M ;
WALKER, E ;
THOMASHUNIS, A ;
GONZALEZ, J ;
GENUTH, S ;
BROWN, E ;
DAHMS, W ;
PUGSLEY, P ;
MAYER, L ;
KERR, D ;
LANDAU, B ;
SINGERMAN, L ;
RICE, T ;
NOVAK, M ;
SMITHBREWER, S ;
MCCONNELL, J ;
DROTAR, D ;
WOODS, D ;
KATIRGI, B ;
LITVENE, M ;
BROWN, C ;
LUSK, M ;
CAMPBELL, R ;
LACKAYE, M ;
RICHARDSON, M ;
LEVY, B ;
CHANG, S ;
HEINHEINEMANN, M ;
BARRON, S ;
ASTOR, L ;
LEBECK, D ;
BRILLON, D ;
DIAMOND, B ;
VASILASDWOSKIN, A ;
LAURENZI, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) :977-986
[24]  
Songer T J, 1995, Pharmacoeconomics, V8 Suppl 1, P1
[25]   DIABETES, OTHER RISK-FACTORS, AND 12-YR CARDIOVASCULAR MORTALITY FOR MEN SCREENED IN THE MULTIPLE RISK FACTOR INTERVENTION TRIAL [J].
STAMLER, J ;
VACCARO, O ;
NEATON, JD ;
WENTWORTH, D .
DIABETES CARE, 1993, 16 (02) :434-444
[26]   MORTALITY IN DIABETIC SUBJECTS - AN 11-YEAR FOLLOW-UP OF A COMMUNITY-BASED POPULATION [J].
WALTERS, DP ;
GATLING, W ;
HOUSTON, AC ;
MULLEE, MA ;
JULIOUS, SA ;
HILL, RD .
DIABETIC MEDICINE, 1994, 11 (10) :968-973
[27]   TESTING 4 COMPETING THEORIES OF HEALTH-PROTECTIVE BEHAVIOR [J].
WEINSTEIN, ND .
HEALTH PSYCHOLOGY, 1993, 12 (04) :324-333
[28]  
WIERENGA ME, 1994, PATIENT EDUC COUNS, V23, P33
[29]   PSYCHOSOCIAL PREDICTORS OF SELF-CARE BEHAVIORS (COMPLIANCE) AND GLYCEMIC CONTROL IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
WILSON, W ;
ARY, DV ;
BIGLAN, A ;
GLASGOW, RE ;
TOOBERT, DJ ;
CAMPBELL, DR .
DIABETES CARE, 1986, 9 (06) :614-622
[30]  
1997, DIABETES CARE, V20, pS14